Accelerating the commercialisation of RNA Therapeutics and Vaccines
Deloitte Supply Chain team as catalyst for RNA supply chains
The context: need for speed
RNA therapeutics refers to the use of very robust mRNA biomolecules (messenger RNA) as means of treating various diseases and medical conditions.
During COVID-19 pandemic, mRNA vaccines - based on spike protein - were able to trigger immune responses, producing antibodies and activating immune cells to fight the virus.
Despite the decrease of demand in COVID-19 vaccines and the natural transition from pandemic to endemic, mRNA technology stays central to the development of new treatments across different fields.
Clinical developments are expected to be approved in the upcoming years; scientists and investors estimates an enormous potential in the use of mRNA for new drug products in many different areas: cancer immunotherapy, infectious disease treatments, personalized vaccines, and many others.
Timing was crucial during the COVID-19 vaccine
Less than one year after the publication of the SARS-CoV-2 sequence, mRNA vaccines against COVID-19 were approved and marketed.
As a matter of fact, the success of mRNA companies during the pandemic was largely driven by their internal capabilities to scale up fast commercial production while maintaining stability and quality of the product.
Since 2020 Deloitte has supported, co-built, and shared the driving seat with the major mRNA players for quickly launching mRNA Covid-19 vaccines worldwide, ensuring high speed and pace in supply chain operations.
We believe the same speed, coupled with numerous lessons learnt on the ground, is essential to driving the success of the new mRNA treatments on the horizon.
Deloitte experts as your mRNA supply chain catalyst
For a Biotech company with a breakthrough product under development and on a fast track to being approved and commercialised, all the pieces of the supply chain puzzle must come together very fast.
Deloitte mRNA supply chain team acts as a catalyst to help you complete your supply chain puzzle in the shortest possible time.
Our proven operational expertise covers various stages of the value chain, encompassing the essential activities for market delivery (“operations” in the puzzle shown below). Furthermore, in addition to the execution of critical tasks, our team provides support across key processes and decision-makings required in short as well as long range planning horizons (“processes”):
Key decision-making cases where our team acted as a catalyst
We list below a selection of the use cases in which our team on the ground has operated, built and advised across topics that could be make or break for an organisation.
Contact our team to hear about our use cases and how we have solved other clients’ problems by applying on-the-ground and consulting expertise in the mRNA field.
